Apple
AAPL
Oracle
ORCL
Adobe
ADBE
Ecopetrol
EC
D.R. Horton
DHI
US Stock MarketDetailed Quotes
BCLI Brainstorm Cell Therapeutics
- 2.250
- +0.460+25.70%
Close Dec 18 16:00 ET
12.83MMarket Cap-0.65P/E (TTM)
2.400High1.780Low494.90KVolume1.840Open1.790Pre Close1.06MTurnover11.32%Turnover RatioLossP/E (Static)5.70MShares11.89052wk High-2.12P/B9.84MFloat Cap1.05052wk Low--Dividend TTM4.37MShs Float787.500Historical High--Div YieldTTM34.64%Amplitude1.050Historical Low2.150Avg Price1Lot Size
About Brainstorm Cell Therapeutics Company
Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function. The company was founded by Irit Arbel on September 22, 2000 and is headquartered in New York, NY.
Company Profile
SymbolBCLI
Company NameBrainstorm Cell Therapeutics
Listing DateMay 9, 2003
Founded2000
CEOMr. Chaim Lebovits
MarketNASDAQ
Employees29
Fiscal Year Ends12-31
Address1325 Avenue of Americas,28th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10019
Phone1-201-488-0460
Company Executives
- Name
- Position
- Salary
- Chaim Lebovits
- President and Chief Executive Officer
- 1.13M
- Dr. Haro Hartounian, PhD
- Executive Vice President and Chief Operating Officer
- --
- Alla Patlis, C.P.A.,M.B.A.
- Interim Chief Financial Officer, Principal Accounting Officer and Controller
- 146.78K
- Dr. Ibrahim B. Dagher
- Executive Vice President and Chief Medical Officer
- --
- Uri Yablonka
- Director, Executive Vice President, Chief Business Officer and Secretary
- 247.06K
- Dr. Hartoun Hartounian, PhD
- Executive Vice President and Chief Operating Officer
- --
- Dr. Irit Arbel, PhD
- Vice Chairman of the Board
- --
- Dr. Jacob A. Frenkel, M.A.,PhD
- Chairman of the Board
- 152.81K
- Dr. Stacy R. Lindborg, PhD
- Director
- 1.01M
- Dr. Anthony J. Polverino, PhD
- Independent Director
- 12.50K
- Dr. Menghisteab Bairu
- Independent Director
- --
- Nir Naor
- Independent Director
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
